95 related articles for article (PubMed ID: 12161135)
1. Novel inhibitors of plasminogen activator inhibitor-1: development of new templates from diketopiperazines.
Wang S; Golec J; Miller W; Milutinovic S; Folkes A; Williams S; Brooks T; Hardman K; Charlton P; Wren S; Spencer J
Bioorg Med Chem Lett; 2002 Sep; 12(17):2367-70. PubMed ID: 12161135
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1.
Folkes A; Roe MB; Sohal S; Golec J; Faint R; Brooks T; Charlton P
Bioorg Med Chem Lett; 2001 Oct; 11(19):2589-92. PubMed ID: 11551756
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of piperazine-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Ye B; Chou YL; Karanjawala R; Lee W; Lu SF; Shaw KJ; Jones S; Lentz D; Liang A; Tseng JL; Wu Q; Zhao Z
Bioorg Med Chem Lett; 2004 Feb; 14(3):761-5. PubMed ID: 14741285
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of plasminogen activator inhibitor-1 activity by two diketopiperazines, XR330 and XR334 produced by Streptomyces sp.
Bryans J; Charlton P; Chicarelli-Robinson I; Collins M; Faint R; Latham C; Shaw I; Trew S
J Antibiot (Tokyo); 1996 Oct; 49(10):1014-21. PubMed ID: 8968395
[TBL] [Abstract][Full Text] [Related]
5. Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1.
Einholm AP; Pedersen KE; Wind T; Kulig P; Overgaard MT; Jensen JK; Bødker JS; Christensen A; Charlton P; Andreasen PA
Biochem J; 2003 Aug; 373(Pt 3):723-32. PubMed ID: 12723974
[TBL] [Abstract][Full Text] [Related]
6. A new class of highly cytotoxic diketopiperazines.
Boger DL; Fink BE; Hedrick MP
Bioorg Med Chem Lett; 2000 May; 10(10):1019-20. PubMed ID: 10843206
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of new N-acylanthranilic acid derivatives as plasminogen activator inhibitor-1 inhibitors.
Yamaoka N; Kodama H; Izuhara Y; Miyata T; Meguro K
Chem Pharm Bull (Tokyo); 2011; 59(2):215-24. PubMed ID: 21297302
[TBL] [Abstract][Full Text] [Related]
8. The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant?
De Taeye B; Gils A; Declerck PJ
Thromb Haemost; 2004 Nov; 92(5):898-924. PubMed ID: 15543316
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of new 2-acylamino-3-thiophenecarboxylic acid dimers as plasminogen activator inhibitor-1 inhibitors.
Yamaoka N; Kawano Y; Izuhara Y; Miyata T; Meguro K
Chem Pharm Bull (Tokyo); 2010 May; 58(5):615-9. PubMed ID: 20460785
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of pyrrolin-2-one compounds, a series of plasminogen activator inhibitor-1 inhibitors.
Miyazaki H; Ogiku T; Sai H; Moritani Y; Ohtani A; Ohmizu H
Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):979-85. PubMed ID: 19721260
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms.
Debrock S; Declerck PJ
Biochim Biophys Acta; 1997 Feb; 1337(2):257-66. PubMed ID: 9048903
[TBL] [Abstract][Full Text] [Related]
12. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1).
Chen F; Zhang G; Hong Z; Lin Z; Lei M; Huang M; Hu L
Bioorg Med Chem Lett; 2014 May; 24(10):2379-82. PubMed ID: 24731276
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
Zeng Y; Li Q; Hanzlik RP; Aubé J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
[TBL] [Abstract][Full Text] [Related]
15. In vitro PAI-1 inhibitory activity of oxalamide derivatives.
Jain MR; Shetty S; Chakrabarti G; Pandya V; Sharma A; Parmar B; Srivastava S; Raviya M; Soni H; Patel PR
Eur J Med Chem; 2008 Apr; 43(4):880-4. PubMed ID: 17664030
[TBL] [Abstract][Full Text] [Related]
16. Diketopiperazine derivatives, a new series of platelet-activating factor inhibitors.
Shimazaki N; Shima I; Hemmi K; Tsurumi Y; Hashimoto M
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3527-30. PubMed ID: 3427732
[No Abstract] [Full Text] [Related]
17. Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F.
Schousboe SL; Egelund R; Kirkegaard T; Preissner KT; Rodenburg KW; Andreasen PA
Thromb Haemost; 2000 May; 83(5):742-51. PubMed ID: 10823273
[TBL] [Abstract][Full Text] [Related]
18. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
19. Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells.
Shi GY; Wang SJ; Chang B; Tasi CF; Lin MT; Chang WC; Wing LY; Jen CJ; Wu HL
Thromb Res; 1996 Jan; 81(1):75-84. PubMed ID: 8747522
[TBL] [Abstract][Full Text] [Related]
20. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA
Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
